[1] |
ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu.
A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
[J]. Chinese Journal of Stroke, 2024, 19(3): 326-330.
|
[2] |
ZHANG Taihui, REN Hong.
A Case Report of Dual Antiplatelet Therapy for Severe Stenosis of the Internal Carotid Artery Based on Rapid CYP2C19 Gene Detection
[J]. Chinese Journal of Stroke, 2024, 19(10): 1131-1134.
|
[3] |
WEN Shaohong, LIU Xiangrong, ZHAO Shunying, DONG Wen, CHEN Qingfang, CHEN Wentao, LI Zixiao, WANG Chunjuan.
Effects of Aspirin Combined with Clopidogrel on the Expression of RAGE and sRAGE during the Convalescence of Cerebral Ischemia in Mice
[J]. Chinese Journal of Stroke, 2022, 17(08): 821-828.
|
[4] |
DONG Wen, JIANG Mingyu, CHEN Wentao, LIU Wenqian, CHEN Qingfang, ZHAO Shunying, YE Weizhen, WEN Shaohong, LIU Xiangrong.
The Effect of Dual Antiplatelet Therapy with Aspirin and Clopidogrel on Inflammatory Response in Bone Marrow and Brain after Cerebral Ischemia Injury in Mice
[J]. Chinese Journal of Stroke, 2022, 17(06): 605-610.
|
[5] |
LI Zhenhua, LIU Zhu, HU Quanzhong.
Progress in Drugs Therapy for Non-disabling Ischemic Cerebrovascular Events
[J]. Chinese Journal of Stroke, 2022, 17(04): 407-412.
|
[6] |
WANG Cong-Jie, LI Hong, ZHENG Li, LIU Shan, LU Hai-Li, CHEN Na, ZHANG Bin, ZHOU Heng.
Efficacy of Dual Antiplatelet Therapy after Intravenous Thrombolysis in Patients with Mild Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(10): 1044-1049.
|
[7] |
CHENG Yue, SHAO Teng-Fei, HUANG Li-Li, YANG Dan, XU Yun.
Platelet Function Test in Predicting the Efficacy and Safety of Clopidogrel Secondary Prevention of Ischemic Stroke#br#
[J]. Chinese Journal of Stroke, 2021, 16(06): 574-580.
|
[8] |
PAN Yue-Song, J. Donald Easton, LI Hao, Anthony S. Kim, MENG Xia,S. Claiborne Johnston, JIN Ao-Ming, WANG Yong-Jun.
Effect of Clopidogrel plus Aspirin Therapy on Functional Outcome in Minor Stroke or Transient Ischemic Attack:Pooled Analysis of CHANCE and POINT
[J]. Chinese Journal of Stroke, 2021, 16(02): 157-162.
|
[9] |
HAO Ya-Nan, SHEN He-Ping,ZHANG Xiao-Ling.
Relationship between CYP2C19 Genotype and Clopidogrel Resistance
[J]. Chinese Journal of Stroke, 2020, 15(07): 740-746.
|
[10] |
YAO Li, ZHANG Xiao-Dong, FAN Song-Hua, SUN Hong, ZHAN Shu-Qin, ZHANG Gui-Lian.
Relationship between High On-treatment Platelet Reactivity, Nut Consumption and Recurrent Atherosclerotic Cerebral Infarction
[J]. Chinese Journal of Stroke, 2019, 14(10): 998-1003.
|
[11] |
ZENG Tao, XIAO Xuan-Hao, XU Bang-Lao, LEI Xiu-Xia, LI Ze, ZHOU Jin, HUANG Hui, PAN Xiao-Ping.
Association of CYP2C19 Gene Polymorphisms with Risk of Recurrent Stroke in First-ever Ischemic Stroke Patients with Clopidogrel for Secondary Prevention
[J]. Chinese Journal of Stroke, 2018, 13(09): 908-914.
|
[12] |
LI Yuan, BIAN Yang, LIU Jian-Guo, QI Xiao-Kun, WANG Zhan-Jun, WANG Wei, QIU Feng.
1-year Efficacy Observation of Clopidogrel versus Aspirin Therapy for Symptomatic Intracranial Artery Stenosis Based on High-resolution Magnetic Resonance Imaging
[J]. Chinese Journal of Stroke, 2018, 13(08): 773-779.
|
[13] |
LIU Yue, HOU Chen, TANG Peng, et al..
The Study of Individualized Treatment of Antiplatelet in Secondary Prevention of Ischemic Stroke
[J]. Chinese Journal of Stroke, 2016, 11(06): 455-461.
|
[14] |
LUO Jian-Hua*, ZHOU Bo-Rong, ZHONG Guang-Hong, SHI Hong-Ting, LIU Yuan-Bo, ZHENG Xuan. .
Relationship between the Level of Mean Platelet Volume and Clopidogrel Resistance in Patients with Ischemic Stroke
[J]. Chinese Journal of Stroke, 2015, 10(01): 50-55.
|
[15] |
SHAO Yuan*,DING Hong, XU Yun..
Genetic Polymorphisms and Antiplatelet Drug Individualized Treatment
[J]. Chinese Journal of Stroke, 2014, 9(04): 309-316.
|